362
Participants
Start Date
April 28, 2023
Primary Completion Date
July 28, 2025
Study Completion Date
July 28, 2025
PLS240
Participants will receive intravenous (IV) PLS240 three times per week for 27 weeks.
Placebo
Participants will receive intravenous (IV) placebo, containing no active drug, three times per week for 27 weeks.
Open-Label Extension PLS240
Participants will receive intravenous (IV) PLS240 three times per week for a maximum of 26 weeks.
Site Number: BGR003-1, Sofia
Site Number: BGR004-1, Sofia
Site Number: BGR002-1, Blagoevgrad
Site Number: BGR001-1, Plovdiv
Site Number: SRB001-1, Belgrade
Site Number: SRB002-1, Zaječar
Site Number: SRB005-1, Novi Sad
Site Number: ESP001-1, Lleida
Site Number: ESP004-1, Madrid
Site Number: ESP005-1, Madrid
Site Number: USA013-1, Dalton
Site Number: ESP003-1, Pamplona
Site Number: SRB003-1, Kragujevac
Site Number: USA028-1, Oxford
Site Number: ESP006-1, Seville
Site Number: ESP002-1, Valencia
Site Number: USA020-1, Fairfield
Site Number: USA016-1, Pine Bluff
Site Number: USA032-1, Anaheim
Site Number: USA031-1, Beverly Hills
Site Number: USA023-1, Fullerton
Site Number: USA030-1, Glendale
Site Number: USA045-1, Oxnard
Site Number: USA046-1, Riverside
Site Number: USA035-1, Salinas
Site Number: USA001-1, San Diego
Site Number: USA021-1, San Diego
Site Number: USA019-1, San Dimas
Site Number: USA036-1, Whittier
Site Number: USA018-1, Denver
Site Number: USA003-1, Lone Tree
Site Number: USA009-1, Hartford
Site Number: USA042-1, Coral Gables
Site Number: USA055-1, Coral Gables
Site Number: USA034-1, Hollywood
Site Number: USA053-1, Atlanta
Site Number: USA027-1, Boise
Site Number: USA007-1, Shelbyville
Site Number: USA026-1, Baton Rouge
Site Number: USA015-1, Columbus
Site Number: USA022-1, Kansas City
Site Number: USA017-1, Las Vegas
Site Number: USA010-1, Jersey City
Site Number: USA008-1, Gallup
Site Number: USA039-1, Manhasset
Site Number: USA011-1, The Bronx
Site Number: USA052-1, Charlotte
Site Number: USA043-1, Greenville
Site Number: USA033-1, Winston-Salem
Site Number: USA040-1, Spartanburg
Site Number: USA049-1, Knoxville
Site Number: USA037-1, Arlington
Site Number: USA024-1, Austin
Site Number: USA056-1, Fort Worth
Site Number: USA014-1, Houston
Site Number: USA012-1, Houston
Site Number: USA025-1, McAllen
Site Number: USA029-1, San Antonio
Site Number: USA005-1, San Antonio
Site Number: USA004-1, San Antonio
Site Number: USA002-1, The Woodlands
Site Number: USA006-1, Norfolk
Site Number: USA050-1, Wauwatosa
Site Number: POL005-1, Oleśnica
Site Number: POL002-1, Żyrardów
Site Number: PRT003-1, Portimão
Site Number: PRT001-1, Carregado
Site Number: PRT002-1, Forte Da Casa
Lead Sponsor
Collaborators (1)
Launch Therapeutics
UNKNOWN
Pathalys Pharma
INDUSTRY